雅本化学年产1500吨四唑虫酰胺原药及其中间体项目竣工环保验收

         近期,甘肃兰沃年产8,710吨农药原药及农药中间体项目阶段性竣工环境保护验收公示。        据项目阶段性竣工环境保护验收公示信…

从单品销售转方案营销,国光股份以作物方案构建客户粘性

         近日,四川国光农化股份有限公司(简称“国光股份”)接待了9家投资机构的调研。公司董事会秘书颜铭、证券事务代表李超、证券投资部副部长向阳参与接待。 &…

环丙氟虫胺:一个中国创制化合物的抗性替代窗口

         7月,泰禾股份正式发布环丙氟虫胺的中文商标”凌翘®“。这是近20年来首个被IRAC(杀虫剂抗药性行动委员会)编入新作用机制分组的中国创制杀虫…

润农集团高效氯氟氰菊酯原药获巴西自主登记

         近日,在润农集团分公司禾锋农业科技(上海)有限公司的推动下,潍坊茂源生物科技有限公司生产的高效氯氟氰菊酯原药正式获得巴西农业部(MAPA)颁发的自主登记证(证号TC2042…

🎥 Inside Faraday Earth’s bid to make cheap green ammonia without Haber-Bosch

[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Faraday Earth] Can a container-sized plasma reactor…

🎥 Can non thermal plasma seed treatment move from lab curiosity to broadacre reality?

[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Sylvarum] Using non-thermal plasma or high voltage …

新型农药产品出海的隐形专利雷区:以氟唑菌酰胺、砜吡草唑为例

以下内容整理自作者在 CPEW 2026 上的主题报告
在全球农药产业格局深刻重塑的背景下,中国农药企业的″出海″征程已从产品竞争转向以知识产权和合规管理为核心的系统性竞争。本文以氟唑菌酰胺、砜吡草唑等热门产品为切入点,深入剖析农药出海面临的专利侵权、样品管控与登记合规三大″隐形雷区″。

Late Rains, Tight Windows Challenge Weed Control In Kansas Row Crops

July 2026, Manhattan: Heavy rains and fast-growing crops are tightening the window for effective herbicide applications …

Report card from California: Farmers and investors need more education on ag biologicals

The ag biologicals sector is still making “steady progress” in terms of new products and overall growth, Dr.…

WuXi AppTec bets on expansion in Europe

WuXi AppTec, the Chinese life sciences services company, is one of the world’s largest providers of research, development, and manufacturing services (CRDMO) for the pharmaceutical and biotechnology industries. The company supports customers across the entire value chain – from early drug discovery through preclinical and clinical development to commercial manufacturing. A science-driven organization, WuXi AppTec has built an international footprint through strategic acquisitions. Its protein design center in Gräfelfing, near Munich, is now being developed into the company’s European center of excellence for drug discovery. We spoke with Steve Yang, PhD, Co-CEO of WuXi AppTec.